FDA Inspection 1179037 — Appco Pharma LLC
The FDA completed an inspection of Appco Pharma LLC on August 19, 2022 in Piscataway, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 19, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Piscataway, NJ (United States)